Pomegranate ellagitannins stimulate growth of gut bacteria invitro: Implications for prebiotic and metabolic effects

Anaerobe

Volumn 34, Issue , 2015, Pages 164-168

  Li, Zhaoping ^a,b,c   Summanen, Paula H ^a   Komoriya, Tomoe ^a,d   Henning, Susanne M ^c   Lee, Ru Po ^c   Carlson, Eliisa ^c   Heber, David ^c   Finegold, Sydney M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NIHON UNIVERSITY   (Japan)

Author keywords

Bifidobacteria; Intestinal bacteria; Lactobacilli; Pomegranate; Pomegranate extract; Pomegranate juice; Prebiotic

Indexed keywords

DRUG METABOLITE; ELLAGIC ACID; ELLAGITANNIN; GLYCOSYL ELLAGIC ACID; HERBACEOUS AGENT; PHENOL; POLYPHENOL; POMEGRANATE EXTRACT; PREBIOTIC AGENT; PUNICALAGIN A; PUNICALAGIN B; PUNICALIN; UNCLASSIFIED DRUG; UROLITHIN; PHENOL DERIVATIVE; SIGNAL PEPTIDE; TANNIN;

ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; CHEMICAL PARAMETERS; CLOSTRIDIA; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG METABOLISM; ENTEROBACTERIACEAE; FECES ANALYSIS; FOLIN CIOCALTEAU COLORIMETRIC METHOD; GALLIC ACID EQUIVALENT; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; POMEGRANATE JUICE; PRIORITY JOURNAL; BACTERIAL LOAD; BACTERIUM; CHEMISTRY; DRUG EFFECTS; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LYTHRACEAE; METABOLISM; MICROBIOLOGY;

BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; CLOSTRIDIA; ENTEROBACTERIACEAE; LACTOBACILLUS; LYTHRACEAE;

BACTERIA; BACTERIAL LOAD; GASTROINTESTINAL TRACT; HUMANS; HYDROLYZABLE TANNINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PHENOLS; PREBIOTICS; PUNICACEAE;

EID: 84935013755     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.05.012     Document Type: Article

References (28)

1. Cani P.D., Osto M., Geurts L., Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012, 3:279-288.
2. Karlsson F., Tremaroli V., Nielsen J., Backhed F. Assessing the human gut microbiota in metabolic diseases. Diabetes 2013, 62:3341-3349.
3. Nicholson J.K., Holmes E., Kinross, et al. Host-gut microbiota metabolic interactions. Science 2012, 336:1262-1267.
4. Neyrinck A.M., Van H.,V., Bindels L.B., et al. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. Br. J. Nutr. 2013, 109:802-809.
5. Spilmont M., Leotoing L., Davicco M.J., et al. Pomegranate and its derivatives can improve bone health through decreased inflammation and oxidative stress in an animal model of postmenopausal osteoporosis. Eur. J. Nutr. 2014, 53:1155-1164.
6. Shukla M., Gupta K., Rasheed Z., et al. Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition 2008, 24:733-743.
7. Shema-Didi L., Sela S., Ore L., et al. One year of pomegranate juice intake decreases oxidative stress, inflammation, and incidence of infections in hemodialysis patients: a randomized placebo-controlled trial. Free Radic. Biol. Med. 2012, 53:297-304.
8. Mertens-Talcott S.U., Jilma-Stohlawetz P., Rios J., Hingorani L., Derendorf H. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J.Agric. Food Chem. 2006, 54:8956-8961.
9. Gomez-Caravaca A.M., Verardo V., Toselli M., Segura-Carretero A., et al. Determination of the major phenolic compounds in pomegranate juices by HPLC-DAD-ESI-MS. J.Agric. Food Chem. 2013, 61:5328-5337.
10. Bialonska D., Ramnani P., Kasimsetty S.G., et al. The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int. J. Food Microbiol. 2010, 140:175-182.
11. Bialonska D., Kasimsetty S.G., Schrader K.K., Ferreira D. The effect of pomegranate (Punica granatum L.) byproducts and ellagitannins on the growth of human gut bacteria. J.Agric. Food Chem. 2009, 57:8344-8349.
12. Reddy M.K., Gupta S.K., Jacob M.R., et al. Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Medica 2007, 73:461-467.
13. Finegold S.M., Summanen P.H., Corbett K., et al. Pomegranate extract exhibits invitro activity against Clostridium difficile. Nutrition 2014, 10:1210-1212.
14. Singleton V.L., Esau P. Phenolic substances in grapes and wine, and their significance. Adv. Food Res. Suppl. 1969, 1:1-261.
15. Heber D., Seeram N.P., Wyatt H., et al. Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size. J.Agric. Food Chem. 2007, 55:10050-10054.
16. Seeram N.P., Henning S.M., Zhang Y., et al. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J.Nutr. 2006, 136:2481-2485.
17. Beerens H. An elective and selective isolation medium for Bifidobacterium spp. Lett. Appl. Microbiol. 1990, 11:155-157.
18. Rogosa M., et al. Aselective medium for the isolation and enumeration of oral and fecal lactobacilli. J.Bacteriol. 1951, 62:132.
19. Jousimies-Somer H.R., Summanen P., Citron D., et al. Wadsworth-KTL Anaerobic Bacteriology Manual 2002, Star Publishing, Belmont, CA. sixth ed.
20. Schwiertz A., Taras D., Schafer K., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obes. (Silver Spring) 2010, 18:190-195.
21. Kalliomaki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 2008, 87:534-538.
22. Collado M.C., Isolauri E., Laitinen K., Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am. J. Clin. Nutr. 2008, 88:894-899.
23. Kondo S., Xiao J.Z., Satoh T., et al. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci. Biotechnol. Biochem. 2010, 74:1656-1661.
24. Neyrinck A.M., Van Hee V.F.L., Bindels B., et al. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. Br. J. Nutr. 2013, 109:802-809.
25. Fawole O.A., Makunga N.P., Opara U.L. Antibacterial, antioxidant and tyrosinase-inhibition activities of pomegranate fruit peel methanolic extract. BMC Complementary Altern. Med. 2012, 12:200.
26. Su X., Howell A.B., D'Souza D.H. Antibacterial effects of plant-derived extracts on methicillin-resistant Staphylococcus aureus. Foodborne Pathogens Dis. 2012, 9:573-578.
27. Panichayupakaranant P., Tewtrakul S., Yuenyongsawad S. Antibacterial, anti-inflammatory and anti-allergic activities of standardized pomegranate rind extract. Food Chem. 2010, 123:400-403.
28. Seeram N.P., Zhang Y., McKeever R., Suchard, et al. Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. J.Med. Food 2008, 11:390-394.